Wildcat Capital Management, LLC Portfolio Holdings

Wildcat Capital Management, LLC

  • $152 Million
  • Q2 2025

Wildcat Capital Management, LLC has filed its 13F form on July 18, 2025 for Q2 2025 where it was disclosed a total value porftolio of $152 Million distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Frontier Group Holdings, Inc. with a value of $102M, Rlx Technology Inc. with a value of $39.9M, Uro Gen Pharma Ltd. with a value of $6.79M, Allogene Therapeutics, Inc. with a value of $3.3M, and Acuren Corp with a value of $0.

Examining the 13F form we can see an decrease of $18.7M in the current position value, from $171M to 152M.

Below you can find more details about Wildcat Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $152 Million
Industrials: $102 Million
Consumer Defensive: $39.9 Million
Healthcare: $10.1 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.41B
$39.9 Million 26.27% of portfolio
18,046,195
Q2 2023 New

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $152 Million
  • Prior Value $171 Million
  • Filing
  • Period Q2 2025
  • Filing Date July 18, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Wildcat Capital Management, LLC Portfolio

Follow Wildcat Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wildcat Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wildcat Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email